Promising ROd-cone DYstrophy Gene therapY
Condition(s):Retinitis PigmentosaLast Updated:June 1, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Retinitis PigmentosaLast Updated:June 1, 2023Recruiting
Condition(s):Inherited Ophthalmic Diseases; Inherited Retinal DegenerationLast Updated:August 13, 2019Terminated
Condition(s):Retinitis PigmentosaLast Updated:December 26, 2023Completed
Condition(s):Retinal DystrophiesLast Updated:December 7, 2023Recruiting
Condition(s):Retinal Degeneration; Inherited Retinal Dystrophy Primarily Involving Sensory RetinaLast Updated:April 19, 2019Terminated
Condition(s):Retinal Disease; Age-Related Macular Degeneration; Retinitis Pigmentosa; Stargardt Disease; Optic Neuropathy; Nonarteritic Ischemic Optic Neuropathy; Optic Atrophy; Optic Nerve Disease; Glaucoma; Leber Hereditary Optic Neuropathy; Blindness; Vision Loss Night; Vision Loss Partial; Vision, Low; Retinopathy; Maculopathy; Macular Degeneration; Retina AtrophyLast Updated:June 6, 2023Recruiting
Condition(s):Retinal Disease; Macular Degeneration; Hereditary Retinal Dystrophy; Optic Nerve Disease; GlaucomaLast Updated:October 23, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.